Background: Hemolytic uremic syndrome (HUS) is a rare but challenging disease with varying degrees of mortality and prognosis. We aim to evaluate the trends and outcomes of hospitalizations due to HUS by utilizing a large population-based dataset.
Methods: We derived a study cohort from the Nationwide Inpatient Sample (NIS) for the years 2007-2018.